Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
16 May 2024
|
|
12:41 | Non-small cell lung cancer, nonsquamous 9 changes history +13,593 [Jwarner (9×)] | |||
| m |
|
12:41 (cur | prev) -200 Jwarner talk contribs →Perioperative therapy | |||
|
|
12:40 (cur | prev) +2,637 Jwarner talk contribs →Carboplatin, Pemetrexed, Durvalumab {{#subobject:cicjbr|Regimen=1}} | ||||
|
|
12:39 (cur | prev) +2,546 Jwarner talk contribs →Carboplatin, Pemetrexed, Durvalumab {{#subobject:cicjbr|Regimen=1}} | ||||
|
|
12:38 (cur | prev) +2,550 Jwarner talk contribs →Cisplatin, Pemetrexed, Durvalumab {{#subobject:cij8er|Regimen=1}} | ||||
| m |
|
12:34 (cur | prev) +2 Jwarner talk contribs | |||
| m |
|
12:33 (cur | prev) -78 Jwarner talk contribs →Advanced or metastatic disease, first-line | |||
| m |
|
12:32 (cur | prev) +2 Jwarner talk contribs | |||
| m |
|
12:26 (cur | prev) +1,150 Jwarner talk contribs →Cisplatin & Pemetrexed {{#subobject:uuhz8q|Regimen=1}} | |||
|
|
12:25 (cur | prev) +4,984 Jwarner talk contribs →Carboplatin & Pemetrexed {{#subobject:ijr18q|Regimen=1}} | ||||
|
|
12:17 | Non-small cell lung cancer, squamous 10 changes history +8,720 [Jwarner (10×)] | |||
|
|
12:17 (cur | prev) +2,560 Jwarner talk contribs →Perioperative therapy | ||||
|
|
12:14 (cur | prev) +2,554 Jwarner talk contribs →Cisplatin & Gemcitabine (GC) & Durvalumab {{#subobject:nctrg3|Regimen=1}} | ||||
| m |
|
12:09 (cur | prev) 0 Jwarner talk contribs →Neoadjuvant therapy | |||
| m |
|
11:33 (cur | prev) +24 Jwarner talk contribs →Neoadjuvant therapy | |||
| m |
|
11:31 (cur | prev) -312 Jwarner talk contribs | |||
| m |
|
11:29 (cur | prev) -249 Jwarner talk contribs →Neoadjuvant therapy | |||
| m |
|
11:08 (cur | prev) +2,124 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) {{#subobject:genmx3|Regimen=1}} | |||
| m |
|
11:03 (cur | prev) +1 Jwarner talk contribs →Docetaxel & Nedaplatin {{#subobject:57cfce|Regimen=1}} | |||
| m |
|
11:03 (cur | prev) 0 Jwarner talk contribs | |||
|
|
11:01 (cur | prev) +2,018 Jwarner talk contribs →Cisplatin & Gemcitabine (GC) {{#subobject:uuhz8q|Regimen=1}} | ||||
| m 10:55 | Non-small cell lung cancer diffhist -80 Jwarner talk contribs →References | ||||
10 May 2024
| m 00:46 | Non-small cell lung cancer, nonsquamous diffhist -11 Jwarner talk contribs →Regimen variant #2, 1200/15/6/175 x 6 {{#subobject:99ed77|Variant=1}} | ||||
7 May 2024
| m 11:21 | Non-small cell lung cancer, squamous diffhist +7 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1450" | ||||
| m 11:21 | Non-small cell lung cancer diffhist +7 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1450" | ||||
| m 11:21 | Non-small cell lung cancer, nonsquamous diffhist +7 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1450" | ||||
6 May 2024
|
|
m 14:55 | Non-small cell lung cancer 2 changes history +7 [Jwarner (2×)] | |||
| m |
|
14:55 (cur | prev) -1 Jwarner talk contribs →NCCN | |||
| m |
|
14:54 (cur | prev) +8 Jwarner talk contribs →NCCN | |||
3 May 2024
|
|
18:59 | Non-small cell lung cancer, squamous 2 changes history +4,715 [Jwarner (2×)] | |||
| m |
|
18:59 (cur | prev) +2,641 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) {{#subobject:c5fbdf|Regimen=1}} | |||
|
|
18:54 (cur | prev) +2,074 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) & Pembrolizumab {{#subobject:1dc8a3|Regimen=1}} | ||||
2 May 2024
|
|
m 01:26 | Immunotherapy toxicity management 3 changes history -2,557 [Jwarner (3×)] | |||
| m |
|
01:26 (cur | prev) -14 Jwarner talk contribs | |||
| m |
|
01:26 (cur | prev) +15 Jwarner talk contribs →Guidelines | |||
| m |
|
01:24 (cur | prev) -2,558 Jwarner talk contribs →Guidelines | |||
23 April 2024
| m 12:44 | Non-small cell lung cancer, nonsquamous diffhist +1,934 Jwarner talk contribs →Carboplatin, Pemetrexed, Atezolizumab {{#subobject:a4hzv7|Regimen=1}} | ||||